Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPI-Cost Trial: Povidone-Iodine Irrigation in Perforated Appendicitis
NCT06705842Phase 4Recruiting
- Sponsor
- UTHealth Houston
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of povidone-iodine in perforated appendicitis (2 arms), sponsored by UTHealth Houston. Primary endpoint: Cost-effectiveness of PVI relative to usual care at 30 days. Started Apr 2025; status: recruiting.
02
Drugs
povidone-iodine
03
Conditions
perforated appendicitis
Beyond the preview
Go deeper on NCT06705842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06705842.